| |
| |
|
| Insider
Information: |
Omenn Gilbert S |
| Relationship: |
Director |
| City: |
Ann Arbor |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
259,816 |
|
|
Indirect Shares
|
164,582 |
|
|
| Direct
Value |
$48,889,490 |
|
|
|
Indirect Value
|
$1,614,898 |
|
|
| Total
Shares |
424,398 |
|
|
| Total
Value |
$50,504,388 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -60.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
Director |
2014-04-25 |
180,547 |
2004-12-09 |
5,590 |
Premium* |
|
|
TearLab Corp |
TEAR |
Director |
2005-10-05 |
2,500 |
2005-10-05 |
0 |
Premium* |
|
|
Galectin Therapeutics Inc |
GALT |
Director |
2019-05-31 |
66,769 |
|
0 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2017-03-21 |
10,000 |
2017-03-21 |
1,000 |
Premium* |
|
|
Amesite Inc. |
AMST |
Director |
|
0 |
2021-12-14 |
77,666 |
Premium* |
|
|
Elicio Therapeutics Ord Shs |
ELTX |
Director |
|
0 |
2021-02-09 |
80,326 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMST |
Amesite Inc. |
Director |
– • – |
2021-12-14 |
4 |
B |
$1.17 |
$9,354 |
I/I |
8,000 |
77,666 |
2.1 |
% |
|
| AMST |
Amesite Inc. |
Director |
– • – |
2021-12-13 |
4 |
B |
$1.18 |
$9,471 |
I/I |
8,000 |
69,666 |
2.1 |
% |
|
| ELTX |
Elicio Therapeutics Ord S... |
Director |
– • – |
2021-02-09 |
4 |
OE |
$11.57 |
$713,371 |
I/I |
61,657 |
80,326 |
0 |
- |
|
| ELTX |
Elicio Therapeutics Ord S... |
Director |
– • – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,669 |
|
- |
|
| AMST |
Amesite Inc. |
Director |
– • – |
2020-09-29 |
4 |
B |
$5.00 |
$100,000 |
I/I |
20,000 |
61,666 |
2.1 |
% |
|
| AMST |
Amesite Inc. |
Director |
– • – |
2020-09-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
41,666 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-05-31 |
4 |
B |
$4.28 |
$79,514 |
D/D |
18,578 |
66,769 |
2.39 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-09-10 |
4 |
S |
$6.00 |
$50,220 |
D/D |
(8,370) |
48,191 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-09-07 |
4 |
S |
$6.03 |
$66,365 |
D/D |
(11,000) |
56,561 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2017-03-21 |
4 |
B |
$42.26 |
$42,260 |
I/I |
1,000 |
1,000 |
2.1 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2016-03-01 |
4 |
B |
$15.28 |
$76,400 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,934 |
67,561 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,506 |
41,627 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
40,121 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2014-10-21 |
4 |
B |
$20.00 |
$100,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,009 |
|
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,009 |
|
- |
|
| AMGN |
Amgen Inc |
Director |
• • – |
2014-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,795 |
180,547 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
• • – |
2013-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,845 |
178,669 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
• • – |
2012-11-26 |
4 |
S |
$87.11 |
$2,264,985 |
D/D |
(26,000) |
176,783 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
• • – |
2012-11-26 |
4 |
OE |
$50.78 |
$1,499,680 |
D/D |
26,000 |
202,783 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
• • – |
2012-10-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,572 |
176,783 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2012-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,395 |
185,313 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2012-02-29 |
4 |
D |
$68.15 |
$293,113 |
D/D |
(4,301) |
183,852 |
0 |
- |
|
| AMGN |
Amgen Inc |
Director |
– • – |
2012-02-29 |
4 |
OE |
$58.61 |
$293,050 |
D/D |
5,000 |
188,153 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
